BRPI0608032A2 - composição para o cuidado do cabelo e/ou do couro cabeludo, método para tratar e/ou prevenir as afecções inflamatórias da pele, uso de um composto de amino-oxo-indol-ilideno e uso de uma composição - Google Patents

composição para o cuidado do cabelo e/ou do couro cabeludo, método para tratar e/ou prevenir as afecções inflamatórias da pele, uso de um composto de amino-oxo-indol-ilideno e uso de uma composição

Info

Publication number
BRPI0608032A2
BRPI0608032A2 BRPI0608032-4A BRPI0608032A BRPI0608032A2 BR PI0608032 A2 BRPI0608032 A2 BR PI0608032A2 BR PI0608032 A BRPI0608032 A BR PI0608032A BR PI0608032 A2 BRPI0608032 A2 BR PI0608032A2
Authority
BR
Brazil
Prior art keywords
composition
hair
amino
oxo
compound
Prior art date
Application number
BRPI0608032-4A
Other languages
English (en)
Inventor
Ranjit Bhogal
Jasveen Chugh
Helen Meldrum
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940571&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0608032(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BRPI0608032A2 publication Critical patent/BRPI0608032A2/pt
Publication of BRPI0608032B1 publication Critical patent/BRPI0608032B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçãO PARA O CUIDADO DO CABELO E/OU DO COURO CABELUDO, MéTODO PARA TRATAR E/OU PREVENIR AS AFECçõES INFLAMATóRIAS DA PELE, USO DE UM COMPOSTO DE AMINO-OXO INDOL-ILIDENO E USO DE UMA COMPOSIçãO. A presente invenção refere-se a uma composição para o cuidado do cabelo e/ou do couro cabeludo que compreende um composto amino-oxo-indol-ilideno de fórmula geral (1) na qual R~ 1~, R~ 2~, R~ 3~ e R~ 4~ são cada, independentemente, hidrogénio ou um grupo monovalente orgânico escolhido entre alquila, alquenila, alquinila, arila, alquilenoarila, cicloalquila, cicloalquenila, e heterociclila.
BRPI0608032-4A 2005-03-12 2006-02-27 composição para o cuidado do cabelo e/ou do couro cabeludo e uso de um composto de amino-oxo-indol-ilideno BRPI0608032B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05251512.9 2005-03-12
EP05251512 2005-03-12
PCT/EP2006/001825 WO2006097193A1 (en) 2005-03-12 2006-02-27 Hair and/or scalp care compositions incorporating amino-oxo-indole-ylidene compounds

Publications (2)

Publication Number Publication Date
BRPI0608032A2 true BRPI0608032A2 (pt) 2009-11-03
BRPI0608032B1 BRPI0608032B1 (pt) 2018-10-16

Family

ID=34940571

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608032-4A BRPI0608032B1 (pt) 2005-03-12 2006-02-27 composição para o cuidado do cabelo e/ou do couro cabeludo e uso de um composto de amino-oxo-indol-ilideno

Country Status (14)

Country Link
US (1) US7807707B2 (pt)
EP (1) EP1893289B1 (pt)
JP (1) JP5047940B2 (pt)
KR (1) KR101238971B1 (pt)
CN (1) CN101175533B (pt)
AR (1) AR053339A1 (pt)
AT (1) ATE472994T1 (pt)
BR (1) BRPI0608032B1 (pt)
CA (1) CA2599349C (pt)
DE (1) DE602006015309D1 (pt)
ES (1) ES2346900T3 (pt)
MX (1) MX2007011142A (pt)
RU (1) RU2403926C2 (pt)
WO (1) WO2006097193A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1923043A1 (en) * 2006-11-16 2008-05-21 KPSS-Kao Professional Salon Services GmbH Anti-dandruff conditioner composition
US9394267B2 (en) 2007-07-13 2016-07-19 The Cleveland Clinic Foundation Heterocyclic modulators of cannabinoid receptors
US8440832B2 (en) 2007-07-13 2013-05-14 Board Of Regents, The University Of Texas System Heterocyclic modulators of cannabinoid receptors
WO2009012227A1 (en) 2007-07-13 2009-01-22 Board Of Regents, The University Of Texas System Hydrazone modulators of cannabinoid receptors
US9079854B2 (en) 2007-07-13 2015-07-14 The Cleveland Clinic Foundation Hydrazone modulators of cannabinoid receptors
JP2015530360A (ja) 2012-07-13 2015-10-15 ザ クリーブランド クリニック ファウンデーションＴｈｅ Ｃｌｅｖｅｌａｎｄ ＣｌｉｎｉｃＦｏｕｎｄａｔｉｏｎ 神経保護ｃｂ２受容体アゴニスト
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
EP2906946A1 (en) 2012-10-09 2015-08-19 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
WO2019121051A1 (en) * 2017-12-20 2019-06-27 Basf Se Novel terpolymers and their use in pharmaceutical dosage forms

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802111A (en) 1956-09-25 1958-10-01 Irwin Irville Lubowe Improved non-toxic pesticidal compositions
LU62030A1 (pt) * 1970-11-10 1972-07-26
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
EP0116439A3 (en) 1983-02-02 1986-01-29 Suntory Limited Fatty acid containing hair tonic composition
IT1233753B (it) 1989-09-21 1992-04-14 Indena Spa Composizioni farmaceutiche ad attivita' sulla microcircolazione cutanea.
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
FR2677223B1 (fr) 1991-06-05 1997-06-06 Jean Gueyne Composition insecticide a base de rotenone, notamment pour le traitement des parasites humains et animaux.
JP3241440B2 (ja) 1992-07-02 2001-12-25 有限会社野々川商事 化粧料
FR2696318B1 (fr) 1992-10-01 1995-12-22 Daniel Sincholle Nouvelles preparations medicamenteuses ou d'hygiene corporelle pour l'elimination des parasites du corps, des cheveux et du cuir chevelu et des poils, contenant une association d'insecticides et de substances anti-oxydantes.
FR2711060B1 (fr) * 1993-10-13 1995-11-17 Oreal Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
IT1278997B1 (it) 1994-07-19 1997-12-02 Indena Spa Combinazioni di sostanze vasoattive con acidi grassi per combattere la caduta dei capelli
US5886031A (en) * 1997-01-27 1999-03-23 Pacific Corporation Hair-care cosmetic compositions having dandruff formation-suppressing effect
JP4002635B2 (ja) 1997-05-27 2007-11-07 花王株式会社 細胞間接着抑制剤
US6451300B1 (en) * 1999-05-03 2002-09-17 The Procter & Gamble Company Anti-dandruff and conditioning shampoos containing polyalkylene glycols and cationic polymers
US6296861B1 (en) 1999-05-03 2001-10-02 Nicholas V. Perricone Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters
DE10036799A1 (de) 2000-07-28 2002-02-07 Beiersdorf Ag Neues Mittel zur Behandlung der Haare und der Kopfhaut
DE10036798A1 (de) 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
DE10126449A1 (de) * 2001-05-31 2002-12-05 Cognis Deutschland Gmbh Haarpflegemittel mit natürlichen Ölen
BR0211251B1 (pt) * 2001-07-18 2013-09-17 composição para o tratamento de cabelo e/ou couro cabeludo.
ES2253495T3 (es) * 2001-09-26 2006-06-01 Pfizer Products Inc. Acidos indol carboxilicos como ligandos de receptores tiroideos.
WO2003037328A1 (en) * 2001-10-30 2003-05-08 Applied Research Systems Ars Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
ITMI20031427A1 (it) 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono
US20080255224A1 (en) * 2007-04-16 2008-10-16 Blum Richard S Pharmacological treatment of psoriasis

Also Published As

Publication number Publication date
ATE472994T1 (de) 2010-07-15
EP1893289A1 (en) 2008-03-05
CA2599349A1 (en) 2006-09-21
US20080206180A1 (en) 2008-08-28
KR20070112384A (ko) 2007-11-23
CN101175533B (zh) 2010-12-22
EP1893289B1 (en) 2010-07-07
AR053339A1 (es) 2007-05-02
JP2008534441A (ja) 2008-08-28
MX2007011142A (es) 2007-11-06
CA2599349C (en) 2014-08-19
DE602006015309D1 (de) 2010-08-19
CN101175533A (zh) 2008-05-07
JP5047940B2 (ja) 2012-10-10
BRPI0608032B1 (pt) 2018-10-16
WO2006097193A1 (en) 2006-09-21
US7807707B2 (en) 2010-10-05
RU2403926C2 (ru) 2010-11-20
ES2346900T3 (es) 2010-10-21
KR101238971B1 (ko) 2013-03-04
RU2007137732A (ru) 2009-04-20

Similar Documents

Publication Publication Date Title
ATE433447T1 (de) Pyrimiidinverbindungen
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
NI201100050A (es) Derivados amida de heteroarilos su uso como activadores de glucoquinasa.
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
CL2008000212A1 (es) Compuestos derivados de fenotiazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar diabetes, reducir los niveles de glucemia, adiccion a nicotina, adiccion al alcohol, trastornos del sistema nervioso central, entre
ECSP088593A (es) 5-(arilsulfonil)-pirazolopiperidinas
BRPI0512352A (pt) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimiocinas
ECSP099296A (es) Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y métodos
BRPI0608032A2 (pt) composição para o cuidado do cabelo e/ou do couro cabeludo, método para tratar e/ou prevenir as afecções inflamatórias da pele, uso de um composto de amino-oxo-indol-ilideno e uso de uma composição
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
BRPI0900983A2 (pt) compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos
BRPI0410316A (pt) composto, composição farmacêutica, uso dos compostos, e, método de tratamento de distúrbios mediados por vr1 e para o tratamento de distúrbios de dores
PA8855001A1 (es) Monocarbamas
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
ECSP21003171A (es) Dinucleótidos cíclicos como agonistas de sting
BRPI0607536A2 (pt) tratamento de dor
EA201070495A1 (ru) МОДУЛЯТОРЫ АКТИВНОСТИ γ-СЕКРЕТАЗЫ ИЗ ГРУППЫ ПИПЕРИДИНИЛА И ПИПЕРАЗИНИЛА
BRPI0508102A (pt) inibidores de caspase e usos dos mesmos
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
BR0010225A (pt) Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 8/49 (2006.01), A61Q 5/00 (2006.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: UNILEVER IP HOLDINGS B.V. (NL)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.